These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 21320484

  • 1. A microarray based expression profiling of paclitaxel and vincristine resistant MCF-7 cells.
    Kars MD, Işeri OD, Gündüz U.
    Eur J Pharmacol; 2011 Apr 25; 657(1-3):4-9. PubMed ID: 21320484
    [Abstract] [Full Text] [Related]

  • 2. Drug resistant breast cancer cells overexpress ETS1 gene.
    Kars MD, Işeri OD, Gündüz U.
    Biomed Pharmacother; 2010 Sep 25; 64(7):458-62. PubMed ID: 20392592
    [Abstract] [Full Text] [Related]

  • 3. cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance.
    Villeneuve DJ, Hembruff SL, Veitch Z, Cecchetto M, Dew WA, Parissenti AM.
    Breast Cancer Res Treat; 2006 Mar 25; 96(1):17-39. PubMed ID: 16322897
    [Abstract] [Full Text] [Related]

  • 4. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
    Ogretmen B, McCauley MD, Safa AR.
    Biochemistry; 1998 Aug 18; 37(33):11679-91. PubMed ID: 9709006
    [Abstract] [Full Text] [Related]

  • 5. Gene expression analysis of drug-resistant MCF-7 cells: implications for relation to extracellular matrix proteins.
    Işeri OD, Kars MD, Arpaci F, Gündüz U.
    Cancer Chemother Pharmacol; 2010 Feb 18; 65(3):447-55. PubMed ID: 19543729
    [Abstract] [Full Text] [Related]

  • 6. Description of paclitaxel resistance-associated genes in ovarian and breast cancer cell lines.
    Duan Z, Lamendola DE, Duan Y, Yusuf RZ, Seiden MV.
    Cancer Chemother Pharmacol; 2005 Mar 18; 55(3):277-85. PubMed ID: 15565326
    [Abstract] [Full Text] [Related]

  • 7. hTERT gene expression levels and telomerase activity in drug resistant MCF-7 cells.
    Sakin V, Eskiocak U, Kars MD, Iseri OD, Gunduz U.
    Exp Oncol; 2008 Sep 18; 30(3):202-5. PubMed ID: 18806742
    [Abstract] [Full Text] [Related]

  • 8. Microarray analysis revealed dysregulation of multiple genes associated with chemoresistance to As(2)O(3) and increased tumor aggressiveness in a newly established arsenic-resistant ovarian cancer cell line, OVCAR-3/AsR.
    Ong PS, Chan SY, Ho PC.
    Eur J Pharm Sci; 2012 Feb 14; 45(3):367-78. PubMed ID: 22178533
    [Abstract] [Full Text] [Related]

  • 9. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
    Kumar A, Soprano DR, Parekh HK.
    Cancer Res; 2001 Oct 15; 61(20):7552-5. PubMed ID: 11606393
    [Abstract] [Full Text] [Related]

  • 10. Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds.
    Kars MD, Iseri OD, Gündüz U, Ural AU, Arpaci F, Molnár J.
    Anticancer Res; 2006 Oct 15; 26(6B):4559-68. PubMed ID: 17201178
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. GBP1 overexpression is associated with a paclitaxel resistance phenotype.
    Duan Z, Foster R, Brakora KA, Yusuf RZ, Seiden MV.
    Cancer Chemother Pharmacol; 2006 Jan 15; 57(1):25-33. PubMed ID: 16028104
    [Abstract] [Full Text] [Related]

  • 16. Differential gene expression profiles in paclitaxel-induced cell cycle arrest and apoptosis in human breast cancer MCF-7 cells.
    Wang J, He FT, Tzang CH, Fong WF, Xiao PG, Han R, Yang MS.
    Yao Xue Xue Bao; 2005 Dec 15; 40(12):1099-104. PubMed ID: 16496673
    [Abstract] [Full Text] [Related]

  • 17. The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines.
    Takeda M, Mizokami A, Mamiya K, Li YQ, Zhang J, Keller ET, Namiki M.
    Prostate; 2007 Jun 15; 67(9):955-67. PubMed ID: 17440963
    [Abstract] [Full Text] [Related]

  • 18. Gene expression profiles with cDNA microarray reveal RhoGDI as a predictive marker for paclitaxel resistance in ovarian cancers.
    Goto T, Takano M, Sakamoto M, Kondo A, Hirata J, Kita T, Tsuda H, Tenjin Y, Kikuchi Y.
    Oncol Rep; 2006 May 15; 15(5):1265-71. PubMed ID: 16596196
    [Abstract] [Full Text] [Related]

  • 19. Drug resistant MCF-7 cells exhibit epithelial-mesenchymal transition gene expression pattern.
    Işeri OD, Kars MD, Arpaci F, Atalay C, Pak I, Gündüz U.
    Biomed Pharmacother; 2011 Feb 15; 65(1):40-5. PubMed ID: 21177063
    [Abstract] [Full Text] [Related]

  • 20. Gene expression profiling of breast tumor cell lines to predict for therapeutic response to microtubule-stabilizing agents.
    Kadra G, Finetti P, Toiron Y, Viens P, Birnbaum D, Borg JP, Bertucci F, Gonçalves A.
    Breast Cancer Res Treat; 2012 Apr 15; 132(3):1035-47. PubMed ID: 21792624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.